GlassScriptPhysician profile
Jess Schwartz
NPI 1912913518
$15,758.27
in general payments reported to CMS, 2019-2025
21 companies · $3,834 in 2025
The $3,834 reported for 2025 was more than what 78% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,329 · 2020: $1,346 · 2021: $167 · 2022: $3,076 · 2023: $4,188 · 2024: $819 · 2025: $3,834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Travel and Lodging: $2,821 · Consulting Fee: $1,868 · Food and Beverage: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Travel and Lodging | $2,820.98 |
| Consulting Fee | $1,867.50 |
| Food and Beverage | $1,152.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,590.26 | 2019-2024 | Ion, Da Vinci Surgical System, Da Vinci Sp |
| Atricure, INC. | $2,134.49 | 2024-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atricure Cryoice Cryosphere Cryoablation System |
| Astrazeneca Pharmaceuticals LP | $2,045.20 | 2021-2025 | Imfinzi, Tagrisso |
| Ethicon INC. | $754.83 | 2019-2020 | |
| Olympus Corporation of The Americas | $455.96 | 2025 | |
| Ethicon US, LLC | $156.76 | 2019-2021 | |
| Covidien LP | $138.31 | 2019 | |
| W. L. Gore & Associates, INC. | $128.54 | 2019-2020 | |
| Abbott Laboratories | $81.48 | 2019 | |
| Depuy Synthes Sales INC. | $79.45 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $22.89 | 2022 | |
| Daiichi Sankyo INC. | $22.49 | 2023 | Enhertu |
| Octapharma USA, INC. | $18.84 | 2025 | Fibryga |
| Genentech USA, INC. | $18.77 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $18.53 | 2025 | Libtayo |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biom'Up France Sas | $18.48 | 2020 | |
| Bard Peripheral Vascular, INC. | $17.38 | 2021 | |
| Davol INC. | $17.35 | 2020 | |
| Cook Medical LLC | $13.80 | 2022 | |
| Reprise Biomedical, INC. | $13.27 | 2021 | |
| Kls-Martin L.P. | $11.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jess Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.